2017 Speaker Evaluations

 

We value your feedback!

Please complete the speaker evaluations for the Global Cardio-Oncology Summit 2017.

Please score questions on a scale of 1 to 5 (poor to excellent), 1 being “poor” and 5 being “excellent”.

 

Dr. Anne Blaes, MD, MS

founder

Session 3: 

Novel pathophysiology of cardiovascular risk with estrogen antagonists

 

Complete Evaluation

Prof. Jutta Bergler-Klein, MD, FESC

founder

Session 4:

How to Treat Radiation-Induced Coronary Disease? Prevention & Treatment

 

Complete Evaluation

Vicki Chambers, BSc(Hons), RGN

founder

Session 10:

The Role of the Clinical Nurse Specialist in Cardio-Oncology

 

Complete Evaluation

Dr. Sinead Clarke, MB.CHB. Dip Pall Med. MRCGP.

founder

Session 5:

Raising Awareness of cardiotoxicity in primary care

 

Complete Evaluation

Prof. Sarah Darby, PhD

founder

Session 4:

Radiation-related heart disease: where are we now?

 

Complete Evaluation

Prof. Sara Faithfull, PhD, MSc, BSc(Hons), RN

founder

Session 5:

Managing cardiovascular risk in cancer patients in primary care

 

Complete Evaluation

Prof. Dimitrios Farmakis, MD, PhD, FESC

founder

Session 9:

Practical matters in atrial fibrillation - anticoagulation & rhythm management

 

Complete Evaluation

Dr. John Groarke, MBBCh, MSc, MPH, MRCPI

founder

 Session 4:

Radiation-induced autonomic dysfunction

 

Complete Evaluation

Prof. Sian Harding

founder

Session 8:

iPSC models to study cardiotoxicity

 

Complete Evaluation

Dr. Joerg Herrmann, MD

founder

Session 10:

Toolkit for success - real world options

 

Complete Evaluation

Prof. Denise Hilfiker-Kleiner

founder

Session 8:

New strategies to protect the heart from cancer therapies

 

Complete Evaluation

Dr. David Hodgson, MD, MPH

founder

Session 4:

A Practical Guide to Minimizing Radiation-related Cardiotoxicity

 

Complete Evaluation

Prof. Michael Kirby, FRCP

founder

Session 5:

Managing cardiovascular risk in cancer patients in primary care

 

Complete Evaluation

Dr. James Larkin, MA, FRCP, PhD

founder

Session 2:

The impact of immunotherapy in treating solid tumours

 

Complete Evaluation

Dr. Daniel Lenihan, MD

founder

Session 1:

Opening Address

 

Complete Evaluation

Dr. Gill Levitt

founder

Session 5:

Lessons from paediatric oncology: How to organize long-term cardiovascular surveillance in cancer survivors

 

Complete Evaluation

Prof. Jane Maher

founder

Session 1 Keynote Lecture:

Cancer survivorship and the impact of cardiovascular disease

 

Complete Evaluation

Dr. Charlotte Manisty, MBBS, MA, MRCP, PhD

founder

Session 7:

How to manage cardiac problems in the bone marrow transplant patient

 

Complete Evaluation

Dr. John McGowan, MBChB, MRCP

founder

Session 10:

Physician Training in Cardio-Oncology

 

Complete Evaluation

Dr. Dragana Milojkovic

founder

Session 7:

BCR-Abl inhibitors and cardiovascular toxicity

 

Complete Evaluation

Dr. Javid Moslehi, MD

founder

Session 2:

Cardiotoxicity caused by immunotherapy

 

Complete Evaluation

Dr. Ann Partridge, MD, MPH

founder

Session 3:

Cardiovascular risk with chronic oestrogen suppression: is there a risk?

 

Complete Evaluation

Dr. Chris J. Plummer, MD

founder

Session 9:

How and why to measure QT and what to do about it?

 

Complete Evaluation

Prof. John Radford

founder

Plenary Lecture:

Long-term cardiovascular outcomes in survivors of Hodgkin's Lymphoma

 

Complete Evaluation

Dr. Stuart D Rosen, MA, MD, FRCP, FESC, FACC, FHFA

founder

Session 3:

Cardiac outcomes of ADT in prostate cancer

 

Complete Evaluation

Dr. Douglas Sawyer, MD, PhD

founder

Session 7:

Proteosomal inhibitors and cardiac complications

 

Complete Evaluation

Prof. Ian E. Smith, MD, FRCP, FRCPE

founder

Plenary Lecture:

HER2 targeted therapies for breast cancer: New insights and cardiac safety

 

Complete Evaluation

Mr. Richard Stephens

founder

Session 1:

Patient's Perspective

 

Complete Evaluation

Dr. Martin Štěrba, PharmD, PhD

founder

Session 8:

Novel insights into mechanisms of dexrazoxane-mediated cardioprotection

 

Complete Evaluation

Prof. Richard Sullivan

founder

Plenary Lecture:

The Global Epidemic of Cancer and Cardiovascular Disease

 

Complete Evaluation

Dr. Karen L. Syrjala, PhD

founder

Plenary Lecture:

e-Health and cardio-oncology

 

Complete Evaluation

Dr. Ashutosh Wechalekar, MB BS, MD, FRPC, FRCPath, DM

founder

Session 7:

Modern advances in the treatment of cardiac amyloid

 

Complete Evaluation

Dr. Ronald Witteles, MD

founder

Session 10:

How should we measure the quality of a cardio-oncology service?

 

Complete Evaluation

Dr. Jay Wright, MBCHB, MD, FRCP

founder

Session 9:

How to manage patients with cardiac pacemakers or defibrillators undergoing cancer surgery or thoracic radiotherapy?

 

Complete Evaluation